Dysregulation of HSG triggers vascular proliferative disorders

Kuang-Hueih Chen1, Xiaomei Guo, Dalong Ma

  • 1The Institute of Cardiovascular Science & The Institute of Molecular Medicine, Peking University, Beijing 100083, China.

Nature Cell Biology
|August 24, 2004
PubMed

Insights

A novel gene, hyperplasia suppressor gene (HSG), also known as rat mitofusin-2, was identified as a key regulator of vascular cell proliferation. Reduced HSG expression is linked to cardiovascular diseases like atherosclerosis and restenosis.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Genetics

Background:

  • Vascular proliferative disorders, including atherosclerosis and restenosis, are leading causes of cardiovascular disease.
  • A common underlying molecular mechanism for these conditions has not been fully elucidated.

Purpose of the Study:

  • To identify and characterize a novel gene involved in suppressing vascular hyperplasia.
  • To investigate the role of this gene in the pathogenesis of vascular proliferative disorders.

Main Methods:

  • Identified and characterized a novel hyperplasia suppressor gene (HSG), later identified as rat mitofusin-2 (rHSG).
  • Assessed HSG expression levels in vascular smooth muscle cells (VSMCs) from various disease models (spontaneously hypertensive rats, balloon-injured rats, ApoE-knockout mice).
  • Evaluated the effect of HSG overexpression on VSMC proliferation in vitro and neointimal hyperplasia in vivo.

Main Results:

  • HSG expression was significantly reduced in hyper-proliferative VSMCs from diseased arteries.
  • Overexpression of HSG suppressed VSMC proliferation, inhibited ERK/MAPK signaling, and induced cell-cycle arrest.
  • HSG effectively blocked balloon injury-induced neointimal VSMC proliferation and restenosis in rat carotid arteries.
  • The anti-proliferative effect was independent of mitochondrial fusion, linked to the p21(ras) motif.

Conclusions:

  • Rat mitofusin-2 (rHSG) functions as a crucial suppressor of vascular cell proliferation.
  • Dysregulation or reduced expression of rHSG contributes to the development of vascular proliferative disorders such as atherosclerosis and restenosis.
  • rHSG represents a potential therapeutic target for cardiovascular diseases.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...